Marshall Perkins & Medical Care Technologies Inc.

Marshall Perkins: Marshall Perkins, CEO of Medical Care Technologies Inc., is leading the strategic evaluation to align the company with the strongest AI infrastructure available, aiming to accelerate commercialization and shareholder value creation.

Medical Care Technologies Inc.: Medical Care Technologies Inc. is strategically evaluating its AI infrastructure and intellectual property to leverage recent advancements from NVIDIA and Anthropic, aiming to accelerate commercialization and enhance shareholder value. This move is expected to improve its technical capabilities and market position.

Marshall Perkins: Marshall Perkins, as the Chief Executive Officer of Medical Care Technologies Inc., is a key figure in articulating the company's vision and strategy for the MDCE Melanoma Scan Beta platform and broader AI initiatives.

Medical Care Technologies Inc.: Medical Care Technologies Inc. is the developer of the MDCE Melanoma Scan Beta platform, an AI-assisted imaging application for skin monitoring. The company is actively engaged in its development, testing, and strategic expansion into healthcare AI.

Marshall Perkins: Marshall Perkins, CEO of Medical Care Technologies Inc., commented on the rapid progress of the company's AI vision technology, emphasizing the focus on deploying and protecting next-generation solutions.

Medical Care Technologies Inc.: Medical Care Technologies Inc. decided not to proceed with its U.S. Provisional Patent Application No. 63/854,935 because its AI vision technology has advanced significantly beyond the original application, demonstrating rapid innovation and a focus on next-generation solutions.